Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Gene Therapy to Target SLAMF7 for Multiple Myeloma by T-CURX for Multiple Myeloma (Kahler Disease): Likelihood of Approval
Gene Therapy to Target SLAMF7 for Multiple Myeloma is under clinical development by T-CURX and currently in Phase I for...